scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · IEX Real-Time Price · USD
4.210
-0.110 (-2.55%)
At close: Jul 2, 2024, 4:00 PM
4.180
-0.030 (-0.71%)
After-hours: Jul 2, 2024, 5:25 PM EDT
scPharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for scPharmaceuticals stock have an average target of 19, with a low estimate of 18 and a high estimate of 20. The average target predicts an increase of 351.31% from the current stock price of 4.21.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 15, 2024.
Analyst Ratings
The average analyst rating for SCPH stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 2 | 2 |
| Buy | 2 | 2 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +327.55% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +327.55% | Mar 14, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +375.06% | Sep 7, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +327.55% | Aug 11, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +327.55% | Aug 2, 2023 |
Financial Forecast
Revenue This Year
40.13M
from 13.59M
Increased by 195.21%
Revenue Next Year
97.64M
from 40.13M
Increased by 143.33%
EPS This Year
-1.49
from -1.42
EPS Next Year
-0.77
from -1.49
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 44.8M | 132.2M | 259.0M | 425.6M | 349.9M |
| Avg | 40.1M | 97.6M | 186.2M | 292.0M | 334.4M |
| Low | 36.2M | 77.0M | 144.2M | 239.8M | 313.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 229.8% | 229.4% | 165.3% | 128.5% | 19.9% |
| Avg | 195.2% | 143.3% | 90.7% | 56.8% | 14.5% |
| Low | 166.1% | 92.0% | 47.6% | 28.8% | 7.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.31 | -0.47 | 1.37 | 3.31 | 3.63 |
| Avg | -1.49 | -0.77 | 0.67 | 2.50 | 3.24 |
| Low | -1.55 | -1.09 | -0.04 | 1.91 | 2.84 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 397.0% | 45.4% |
| Avg | - | - | - | 275.5% | 29.8% |
| Low | - | - | - | 187.1% | 13.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.